Attached files

file filename
10-K - OXIS ANNUAL REPORT 2009 - GT Biopharma, Inc.oxis10k2009.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER - GT Biopharma, Inc.ex312.htm
EX-21.1 - OXIS SUBSIDIARIES - GT Biopharma, Inc.ex211.htm
EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - GT Biopharma, Inc.ex311.htm
EX-32.2 - SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER - GT Biopharma, Inc.ex322.htm
EX-10.20 - EMPLOYMENT AGREEMENT BY AND BETWEEN OXIS AND BERNARD LANDES, DATED MARCH 11, 2010 - GT Biopharma, Inc.ex1020.htm
EX-10.19 - ADVISORY AGREEMENT, BETWEEN OXIS INTERNATIONAL, INC. AND GARY M. POST - GT Biopharma, Inc.ex1019.htm
EX-10.17 - EMPLOYMENT AGREEMENT BY AND BETWEEN OXIS AND MICHAEL HANDELMAN, DATED MARCH 11, 2010 - GT Biopharma, Inc.ex1017.htm
EX-10.14 - ESCROW AGREEMENT BY AND AMONG OXIS, THEOREM GROUP, LLC, THEOREM CAPITAL, LLC AND LAW OFFICES OF JACQUES CHEN - GT Biopharma, Inc.ex1014.htm
EX-10.18 - EMPLOYMENT AGREEMENT, DATED MARCH 26, 2010, BETWEEN OXIS INTERNATIONAL, INC. AND ANTHONY J. CATALDO - GT Biopharma, Inc.ex1018.htm



Exhibit 32.1


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Oxis International, Inc. (the “Company”) for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Anthony J. Cataldo, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated:  March 30, 2010
By: /s/ Anthony J. Cataldo
 
Anthony J. Cataldo
 
Chief Executive Officer

This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.